partnering

News

BMS adds to IBD pipeline with $1.9bn GentiBio deal

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD).

News

Closeup of X-ray photography of human brain

Merck swings back into Alzheimer's with $1.1bn Cerevance all...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevan

News

Fake Dictionary, Dictionary definition of the word Schizophrenia.

Sosei Heptares banks $30m milestone in Neurocrine Bio allian...

Sosei Heptares has taken another of its partnered G protein-coupled receptor (GPCR) programmes into mid-stage clinical trials, earning a $30 million milestone payment from Neurocrine Biosci

News

Sanofi looks east with €300m Innovent cancer alliance

Sanofi is making a €300 million investment in Chinese biotech Innovent as part of a collaboration to bring two new cancer therapies as quickly as possible to patients in the world's second-

News

Roche adds to pipeline with Poseida, Kiniksa deals

Roche has announced a pair of licensing deals with Poseida Therapeutics and Kiniksa Pharmaceuticals that bolster its pipeline in cancer and inflammatory diseases.

News

AbbVie taps Sosei Heptares GPCR expertise with $1.2bn+ allia...

Sosei Heptares has signed up a string of big pharma collaborators over the last few years, and one of them – AbbVie – has just expanded its partnership with a new to deal to apply the biote

BMS adds to IBD pipeline with $1.9bn GentiBio deal

Merck swings back into Alzheimer's with $1.1bn Cerevance all...

Sosei Heptares banks $30m milestone in Neurocrine Bio allian...

Sanofi looks east with €300m Innovent cancer alliance

Roche adds to pipeline with Poseida, Kiniksa deals

AbbVie taps Sosei Heptares GPCR expertise with $1.2bn+ allia...

NHS study launched to tackle antimicrobial resistance threat

Discover a new era of healthcare panel engagement: Grounded ...

partnering

Editor's Picks